vs
HomeTrust Bancshares, Inc.（HTB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是HomeTrust Bancshares, Inc.的1.4倍（$75.5M vs $53.6M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 3.7%），HomeTrust Bancshares, Inc.自由现金流更多（$45.3M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 3.5%）
HomeTrust Bancshares, Inc.是总部位于美国北卡罗来纳州阿什维尔的银行控股公司，总资产达43亿美元，在北卡、南卡、佐治亚和田纳西州共设有33家网点，旗下拥有HomeTrust银行、Tryon联邦银行等七家社区银行。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HTB vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$53.6M
营收增速更快
PBYI
高出24.1%
3.7%
自由现金流更多
HTB
多$30.9M
$14.4M
两年增速更快
PBYI
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.6M | $75.5M |
| 净利润 | — | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 37.0% | 22.7% |
| 净利率 | — | — |
| 营收同比 | 3.7% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.93 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTBPBYI
| Q4 25 | $53.6M | $75.5M | ||
| Q3 25 | $54.1M | $54.5M | ||
| Q2 25 | $54.4M | $52.4M | ||
| Q1 25 | $50.9M | $46.0M | ||
| Q4 24 | $51.7M | $59.1M | ||
| Q3 24 | $50.6M | $80.5M | ||
| Q2 24 | $50.6M | $47.1M | ||
| Q1 24 | $50.0M | $43.8M |
净利润HTBPBYI
| Q4 25 | — | — | ||
| Q3 25 | $16.5M | $8.8M | ||
| Q2 25 | $17.2M | $5.9M | ||
| Q1 25 | $14.5M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.1M | $20.3M | ||
| Q2 24 | $12.4M | $-4.5M | ||
| Q1 24 | $15.1M | $-4.8M |
毛利率HTBPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率HTBPBYI
| Q4 25 | 37.0% | 22.7% | ||
| Q3 25 | 38.5% | 17.6% | ||
| Q2 25 | 40.1% | 12.7% | ||
| Q1 25 | 36.2% | 8.7% | ||
| Q4 24 | 35.4% | 22.6% | ||
| Q3 24 | 33.2% | 27.4% | ||
| Q2 24 | 31.3% | -4.6% | ||
| Q1 24 | 38.0% | -5.3% |
净利率HTBPBYI
| Q4 25 | — | — | ||
| Q3 25 | 30.5% | 16.2% | ||
| Q2 25 | 31.6% | 11.2% | ||
| Q1 25 | 28.5% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.9% | 25.2% | ||
| Q2 24 | 24.6% | -9.6% | ||
| Q1 24 | 30.1% | -11.0% |
每股收益（稀释后）HTBPBYI
| Q4 25 | $0.93 | $0.26 | ||
| Q3 25 | $0.95 | $0.17 | ||
| Q2 25 | $1.00 | $0.12 | ||
| Q1 25 | $0.84 | $0.06 | ||
| Q4 24 | $0.83 | $0.40 | ||
| Q3 24 | $0.76 | $0.41 | ||
| Q2 24 | $0.73 | $-0.09 | ||
| Q1 24 | $0.88 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $324.7M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $600.7M | $130.3M |
| 总资产 | $4.5B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HTBPBYI
| Q4 25 | $324.7M | $97.5M | ||
| Q3 25 | $315.8M | $94.4M | ||
| Q2 25 | $297.2M | $96.0M | ||
| Q1 25 | $299.8M | $93.2M | ||
| Q4 24 | $279.2M | $101.0M | ||
| Q3 24 | $293.5M | $96.7M | ||
| Q2 24 | $294.2M | $96.8M | ||
| Q1 24 | $380.5M | $107.2M |
总债务HTBPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益HTBPBYI
| Q4 25 | $600.7M | $130.3M | ||
| Q3 25 | $595.8M | $115.3M | ||
| Q2 25 | $579.3M | $104.7M | ||
| Q1 25 | $565.4M | $97.1M | ||
| Q4 24 | $551.8M | $92.1M | ||
| Q3 24 | $540.0M | $71.1M | ||
| Q2 24 | $523.6M | $48.5M | ||
| Q1 24 | $513.2M | $51.0M |
总资产HTBPBYI
| Q4 25 | $4.5B | $216.3M | ||
| Q3 25 | $4.6B | $202.9M | ||
| Q2 25 | $4.6B | $194.9M | ||
| Q1 25 | $4.6B | $196.2M | ||
| Q4 24 | $4.6B | $213.3M | ||
| Q3 24 | $4.6B | $220.7M | ||
| Q2 24 | $4.7B | $205.0M | ||
| Q1 24 | $4.7B | $214.1M |
负债/权益比HTBPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $49.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $45.3M | $14.4M |
| 自由现金流率自由现金流/营收 | 84.5% | 19.1% |
| 资本支出强度资本支出/营收 | 7.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $93.8M | $41.7M |
8季度趋势，按日历期对齐
经营现金流HTBPBYI
| Q4 25 | $49.5M | $14.4M | ||
| Q3 25 | $-11.3M | $9.7M | ||
| Q2 25 | $-8.8M | $14.1M | ||
| Q1 25 | $71.7M | $3.6M | ||
| Q4 24 | $45.4M | $15.6M | ||
| Q3 24 | $43.8M | $11.0M | ||
| Q2 24 | $5.9M | $1.0M | ||
| Q1 24 | $-9.0M | $11.2M |
自由现金流HTBPBYI
| Q4 25 | $45.3M | $14.4M | ||
| Q3 25 | $-12.0M | $9.7M | ||
| Q2 25 | $-10.2M | $14.1M | ||
| Q1 25 | $70.7M | $3.6M | ||
| Q4 24 | $42.4M | $15.6M | ||
| Q3 24 | $43.1M | $11.0M | ||
| Q2 24 | $5.7M | $1.0M | ||
| Q1 24 | $-9.6M | — |
自由现金流率HTBPBYI
| Q4 25 | 84.5% | 19.1% | ||
| Q3 25 | -22.2% | 17.7% | ||
| Q2 25 | -18.7% | 26.8% | ||
| Q1 25 | 138.7% | 7.7% | ||
| Q4 24 | 82.0% | 26.4% | ||
| Q3 24 | 85.1% | 13.7% | ||
| Q2 24 | 11.2% | 2.1% | ||
| Q1 24 | -19.2% | — |
资本支出强度HTBPBYI
| Q4 25 | 7.8% | 0.0% | ||
| Q3 25 | 1.4% | 0.0% | ||
| Q2 25 | 2.5% | 0.0% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 5.9% | 0.0% | ||
| Q3 24 | 1.3% | 0.0% | ||
| Q2 24 | 0.5% | 0.0% | ||
| Q1 24 | 1.1% | 0.0% |
现金转化率HTBPBYI
| Q4 25 | — | — | ||
| Q3 25 | -0.68× | 1.10× | ||
| Q2 25 | -0.51× | 2.41× | ||
| Q1 25 | 4.93× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.34× | 0.54× | ||
| Q2 24 | 0.48× | — | ||
| Q1 24 | -0.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
